12:00 AM
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TroVax: Phase II started

Oxford BioMedica said researchers at Cardiff University (Cardiff, U.K.) began the open-label, U.K. Phase II TaCTiCC trial to evaluate TroVax with or without cyclophosphamide in up to 54 patients....

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >